For research use only. Not for therapeutic Use.
<p>
<span style="font-family:arial,helvetica,sans-serif;"><span style="font-size:12px;">Diazoxide (CAS 364-98-7) is the activator of ATP-dependent K<sup>+</sup> channels used for antihypertensive and <span style="caret-color: rgb(33, 33, 33); color: rgb(33, 33, 33); orphans: 2; widows: 2;">hyperglycemic activities. </span><span style="color: rgb(33, 33, 33); font-variant-ligatures: normal; orphans: 2; widows: 2;">Diazoxide increases membrane permeability to potassium</span><span style="color: rgb(33, 33, 33); font-variant-ligatures: normal; orphans: 2; widows: 2;"> ions in vascular smooth muscle, thereby stabilizing the membrane action potential and preventing vascular smooth muscle contraction; this results in peripheral vasodilatation and decreases in peripheral vascular resistance. This agent also inhibits insulin release by interacting with ATP-sensitive potassium channels of pancreatic islet beta-cells.</span></span></span></p>
<br />
Catalog Number | A000072 |
CAS Number | 364-98-7 |
Synonyms | ch-6783, SRG-95213, Proglycem |
Molecular Formula | C8H7ClN2O2S |
Purity | ≥95% |
Target | AMPAR |
Solubility | >10.4mg/mL in DMSO |
Storage | Store at RT |
Overview of Clinical Research | <span style="font-family: arial, helvetica, sans-serif;">Diazoxide is a potassium channel agonist, which used for antihypertensive and antihypoglycaemics.</span> |
IUPAC Name | 7-chloro-3-methyl-4H-1λ6,2,4-benzothiadiazine 1,1-dioxide |
InChI | InChI=1S/C8H7ClN2O2S/c1-5-10-7-3-2-6(9)4-8(7)14(12,13)11-5/h2-4H,1H3,(H,10,11) |
InChIKey | GDLBFKVLRPITMI-UHFFFAOYSA-N |
SMILES | CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl |
Reference | 1. Quast et al., /In vitro and in vivo comparison of two K+ channels openers, Diazoxide and Cromakalim, and their inhibition by Glibenclamide./ <i>J. Pharmacol. Exp. Ther.</i> (1989). 250(1):261-271<br /> |